Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003

Abstract

Use of statins across Europe has increased hugely over the study period. Some of the increase in use is due to higher prescribed daily doses, but two-thirds is due to increases in numbers of patient days of treatment, either due to more patients treated or less likely to better compliance.